✦ LIBER ✦

A knowledge translation challenge: clinical use of quality of life data from cancer clinical trials

✍ Scribed by Michael Brundage; Brenda Bass; Ringash Jolie; Kimberley Foley

Book ID: 106510731
Publisher: Springer Netherlands
Year: 2011
Tongue: English
Weight: 258 KB
Volume: 20
Category: Article
ISSN: 0962-9343
DOI: 10.1007/s11136-011-9848-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Missing quality of life data in cancer c

Missing quality of life data in cancer clinical trials: serious problems and challenges

✍ Jürg Bernhard; David F. Cella; Alan S. Coates; Lesley Fallowfield; Patricia A. G 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 2 views

Measurement of quality of life (QOL) in cancer clinical trials has increased in recent years as more groups realize the importance of such endpoints. A key problem has been missing data. Some QOL data may unavoidably be missing, as for example when patients are too ill to complete forms. Other impor

Statistical analysis of quality of life

Statistical analysis of quality of life with missing data in cancer clinical trials

✍ Andrea B. Troxel; Diane L. Fairclough; Desmond Curran; Elizabeth A. Hahn 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 3 views

We summarize issues that arise when considering quality of life (QOL) data in cancer clinical trials, especially those related to missing data. We describe different types of missing data mechanisms, and discuss ways of assessing and testing missing data mechanisms. A section on presentation of stud

Suggestions for the presentation of qual

Suggestions for the presentation of quality of life data from clinical trials

✍ David Machin; Simon Weeden 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB 👁 2 views

Quality of life (QOL) data is complex since it is both multidimensional and longitudinal. This complexity is compounded with its unbalanced nature through missing observations as a consequence of patient non-compliance with assessment schedules, and, for example, in cancer clinical trials data absen

Why are missing quality of life data a p

Why are missing quality of life data a problem in clinical trials of cancer therapy?

✍ Diane L. Fairclough; Harriet F. Peterson; Victor Chang 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 3 views

Assessment of health related quality of life has become an important endpoint in many cancer clinical trials. Because the participants of these trials often experience disease and treatment related morbidity and mortality, non-random missing assessments are inevitable. Examples are presented from se

Identifying the types of missingness in

Identifying the types of missingness in quality of life data from clinical trials

✍ D. Curran; M. Bacchi; S. F. Hsu Schmitz; G. Molenberghs; R. J. Sylvester 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 2 views

This paper discusses methods of identifying the types of missingness in quality of life (QOL) data in cancer clinical trials. The first approach involves collecting information on why the QOL questionnaires were not completed. Based on the reasons provided one may be able to distinguish the mechanis

Challenges posed by non-random missing q

Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial

✍ Carol M. Moinpour; Julia Sawyers Triplett; Barbara McKnight; Laura C. Lovato; Ch 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views